This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why You Should Hold Procter & Gamble (PG) for Now
by Zacks Equity Research
Procter & Gamble (PG) remains well-poised on the back of brand strength, solid top-line growth and cost-saving plans. However, higher-than-anticipated commodity and freight costs are concerning.
Hain Celestial (HAIN) Q1 Earnings in Focus: Things to Note
by Zacks Equity Research
Hain Celestial's (HAIN) first-quarter performance is likely to have been affected by moderation of at-home dining trends.
B&G Foods (BGS) Q3 Earnings Miss Estimates, Sales Up Y/Y
by Zacks Equity Research
B&G Foods' (BGS) third-quarter fiscal 2021 results reflect lower earnings. Input cost inflation hurts quarterly results, while higher demand was a tailwind.
Medifast (MED) Raises View on Q3 Earnings & Revenue Beat
by Zacks Equity Research
Medifast's (MED) third-quarter 2021 results reflect stellar earnings and revenues, courtesy of continued strength in OPTAVIA. Management raises earnings per share and revenue guidance for 2021.
Kellogg's (K) Q3 Earnings & Revenues Top Estimates, Up Y/Y
by Zacks Equity Research
Kellogg's (K) third-quarter 2021 results reflect higher earnings and sales. Management ups organic sales guidance.
Mondelez (MDLZ) Q3 Earnings Beat Estimates, Revenues Up
by Zacks Equity Research
Mondelez's (MDLZ) third-quarter 2021 results reflect a rise in earnings and revenues. Solid to-date results led to a raised organic revenue growth view, though high costs are a concern.
Analysts Estimate Hain Celestial (HAIN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Hain Celestial (HAIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bear of the Day: Hain Celestial (HAIN)
by David Bartosiak
An earnings miss started a string of negative earnings estimate revisions for this stock.
ScanSource, Hain Celestial, MGM Resorts, Caesars Entertainment and Genius Sports highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
ScanSource, Hain Celestial, MGM Resorts, Caesars Entertainment and Genius Sports highlighted as Zacks Bull and Bear of the Day
New Strong Sell Stocks for September 1st
by Zacks Equity Research
BILL, DLTR, SBSW, and HAIN have been added to the Zacks Rank #5 (Strong Sell) List on September 1, 2021.
Hain Celestial (HAIN) Q4 Earnings Miss Estimates, Sales Down
by Zacks Equity Research
Hain Celestial's (HAIN) fourth-quarter performance reflects impacts of overlapping pandemic-led volume surge witnessed in the prior-year quarter.
Hain Celestial (HAIN) Q4 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Hain Celestial (HAIN) delivered earnings and revenue surprises of -2.50% and -2.52%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Hain Celestial (HAIN) Q4 Earnings in Focus: Things to Note
by Zacks Equity Research
Hain Celestial's (HAIN) fourth-quarter fiscal 2021 results are likely to reflect gains from transformation plan. However, net sales are expected to have declined year-over-year.
Hain Celestial (HAIN) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Hain Celestial (HAIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hain Celestial (HAIN) Aims to Boost Brands & Build Efficiency
by Zacks Equity Research
Hain Celestial's (HAIN) transformation strategy includes simplifying portfolio and building cost efficiency.
Hain Celestial (HAIN) Boosts Brands With New Healthy Offerings
by Zacks Equity Research
Hain Celestial (HAIN) is launching several new products in snacks, teas and personal care.
Get Over the Meme Frenzy, Dig Into These 4 Food Stocks Instead
by Vrishali Bagree
Food stocks like Darling Ingredients (DAR), Medifast (MED), Hain Celestial (HAIN) and Nomad Foods (NOMD) are great investment options for those looking to bypass the meme craze.
Purple Innovation (PRPL) Lowers Q2 & Withdraws 2021 Outlook
by Zacks Equity Research
Purple Innovation (PRPL) trims second-quarter 2021 outlook due to production threats triggered by unexpected mechanical and maintenance snags.
3 Stocks to Make the Most of Healthy Demand for Organic Food
by Kaustav Ghosh
Organic food seems set to witness further growth as people regard them as healthier alternatives, making it wise to look at names like Hain Celestial (HAIN), Kroger (KR) and Sprouts Farmers Market (SFM).
Archer Daniels (ADM) Gains on Strategic Moves & Nutrition Unit
by Zacks Equity Research
Archer Daniels (ADM) smoothly advances on its growth pillars that assure to optimize the core, drive efficiencies and expand strategically.
Hain Celestial (HAIN) on Track With Transformation Strategy
by Zacks Equity Research
Hain Celestial's (HAIN) transformation strategy includes simplifying portfolio and identifying areas of productivity savings. Tough year-on-year comparison due to lapping of pandemic-led benefits is a downside.
Campbell Soup (CPB) Looks Troubled: Cost Inflation a Major Hurdle
by Zacks Equity Research
Campbell Soup (CPB) is battling margin concerns due to elevated inflation, a rise in supply-chain expenses and some executional headwinds related to the transformation plan. Management recently cut the EPS view.
Sysco's (SYY) Recipe for Growth Solid, International Sales Soft
by Zacks Equity Research
Sysco Corporation (SYY) is well placed, thanks to its Recipe for Growth and business transformation efforts. However, International unit sales have been soft due to lockdowns in certain regions.
Chewy (CHWY) Q1 Earnings & Sales Beat Estimates, Rise Y/Y
by Zacks Equity Research
Chewy (CHWY) posts better-than-expected results for first-quarter fiscal 2021. Notably, growth in active customers aids the top line.
Hain Celestial (HAIN) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Hain Celestial (HAIN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).